Ambu : Chairman of the Board of Directors will not seek re-election (no .1)

Chairman of the Board of Directors will not seek re-election

Lars Rasmussen, who has been chairman of the Board of Directors in Ambu A/S since December 2019, has decided not to seek re-election at the Annual General Meeting in December 2020.

"It has been brought to my attention, that certain Ambu shareholders are of the opinion that there is a potential conflict of interest by me being chairman of the Board of Directors in both Ambu and Coloplast. The reason is, that Coloplast during its recent Capital Markets Day mentioned that they might sometime in the future evaluate if distribution of cystoscopes could be a new product area to enter. Based on this potential future uncertainty, I have decided not to seek re-election as chairman of the Board of Directors in Ambu to make sure that I and the company apply to the highest corporate governance standards," says Lars Rasmussen about the unexpected departure from Ambu.

Oliver Johansen, who has been a member of the Board in Ambu A/S since 2015 and who is SVP, Global R&D with Colo- plast, has also decided not to seek re-election at the Annual General Meeting for the same reason as Lars Rasmussen.

The search for new candidates will be initiated in line with Ambu's Board succession planning process.

The entire Board would like to thank Lars Rasmussen as well as Oliver Johansen for their contribution to Ambu's successful development during their tenure.

Contact

Lars Rasmussen, chairman of the Board of Directors, tel. [phone].

Ambu A/S Baltorpbakken 13

2750 Ballerup, Denmark Tel. [phone] CVR no.: 63 64 49 19 www.ambu.com

About Ambu

Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ - the world's first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near Copenhagen in Denmark, Ambu employs approximately 4,000 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com.

Ambu
Company announcement no. 1 2020/21	9 October 2020	Page 1 of 1